The workshop will be abstract-driven and will be guided by cross-cutting themes in the field of  adolescent health and HIV care. Each session will include an invited plenary session on a key issue in the field, followed by abstract presentations, debates, and discussions. 

 Wednesday 2 October - Day 1

Version 11 July 2019
 Youth Leadership Program

9:00 -

Youth Leadership Program 
Designed by youth for youth
 13:00   Lunch
 Official Opening of the Workshop

Vision and Aims
Elizabeth, MBChB, MD,MPH, PhD,
Kenya Medical Research Institute, Kenya
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD,
University of Cape Town / Desmond Tutu HIV Foundation, South Africa
Rebecca Nyambeki,
National AIDS Control Council, Kenya

 14:15Opening Address

 Session 1: Structural and Systematic Barriers 
Session Chairs: Rebecca Nyambeki & Linda-Gail Bekker

 14:45Keynote Lecture
 15:15Abstract #1
 15:25Abstract #2
 15:35Abstract #3
 15:45Q & A and Panel Discussion
 16:00   Tea Break and Poster Viewing

 Session 2: Youth leadership, engagement and advocacy 
Session Chairs: Seifu Ibrahim Goga & Talimba Bandawe

 16:30Keynote Presentation
 17:10Abstract #4
 17:20Abstract #5
 17:30Abstract #6 
 17:30Abstract #7 
 17:40Q & A and Panel Discussion
 17:55Wrap-Up Day 1
 Poster Viewing and Welcome Reception   

Thursday 3 October - Day 2

 07:30Welcome Tea
 Session 3: Skills-Building Sessions

Aiming High for Meaningful Youth Leadership and Engagement
Audrey Nosenga 
Zimbabwe Young Positives (ZY+)
Tinashe Rufurwadzo
Global Network of Young People Living with HIV (Y+) 
Seifu Ibrahim,
AfriYAN, Tanzania

 Using Data to Inform Programming
Fletcher Chiu,
PLHIV Stigma Index to Persons with HIV/AIDS Rights Advocacy Association, Taiwan

Funding: Where is the Money? Top Tips for Raising Funds
Lubna Bhayani,
Frontline AIDS
Eddy Rudram,
Youth LEAD, Thailand

 Communications for Advocacy 
Rick Evans,
Ogilvy, United Kingdom
Saidy Brown,
Y+, South Africa
  10:00  Tea Break and Poster Viewing
  Session 4: Biomedical Interventions and Clinical Management
 10:30Keynote Presentation - Prevention
Nyaradzo Mavis Mgodi, MBChB, MMed, 
University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Zimbabwe
 11:00Keynote Presentation - Treatment
Wipaporn Natalie Songtaweesin, MBBS, 
Chulalongkorn University, Thailand 
 11:30Abstract #4
 11:40Abstract #5
 11:50Q & A and Discussion 
 12:00   Symposium
 13:00   Lunch
 Session 5: Intervention and Service Delivery Approaches 
 14:00 Keynote Presentation 
 14:30Abstract #6
 14:40Abstract #7
 14:50Abstract #8
 15:00Abstract #9
 15:10Abstract #10
 15:20Q & A and Discussion
 15:30   Tea break
  Session 6: Communications and Behavior Change: Interpersonal to Mass Media
 16:00Keynote Presentation 
Georgina Caswell,
Frontline AIDS, South Africa 
 16:30Abstract #11
 16:40Abstract #12
 16:50Abstract #13
 17:00Q & A and Discussion
 17:10  Poster Viewing
 18:00  Marketplace: Innovation to Scale, Sharing Space for Research and Implementation
For all interested organizations. If you are interested, please send an email to
             Sam Jackson 
 19:00    Networking Dinner

Friday 4 October - Day 3

 Session 7  Mental Health and Psychosocial Support 
Session chairs: Fletcher Chiu & Victor Musiime
 08:30 Keynote Presentation
Sarah Bernays, PhD
University of Sydney
 09:00Abstract #14
 09:10Abstract #15
 09:20Abstract #16
 09:30Abstract #17
 09:40Abstract #18
 09:50Q & A and Discussion
 10:00  Tea Break
 10:30 Symposium EGPAF
Session 8: Scaling Up Interventions: Improving the Quality and Sustainability of Programs
Session chairs: Phyllis Mavushe & Alice Armstrong
 11:30Keynote Lecture
Nametsego Tswetla,
Ministry of Health, Botswana
 12:00Abstract #19
 12:10Abstract #20
 12:20Abstract #21
 12:30Q&A and Discussion
 12:40Summary and Way Forward
 12:50   Lunch



IVHEM 2019 will feature an exceptional program addressing the most pressing issues concerning the 2030 elimination target for viral hepatitis. We will address challenges faced in various settings and countries.

Click here to view the latest program: Program

Confirmed sessions for this year's IVHEM include but are not limited to:

Prevention with presentations by Dr. Jie Li and Mark Tyndall
Monitoring and Testing with presentations by Dr. Manal El-Sayed and Kenneth Kabagambe
Model for Care - Focus on HBV with presentations by Dr. Jordan Feld, Prof. Huma Qureshi, and Dr. Hailemichael Desalegn Mekonnen
- Model for Care - Focus on HCV with presentations by Prof. Margaret Hellard, Dr. Naranjargal J. Dashdorj, and Dr. Sunil Solomon.


In 2018, our program featured speakers from 18 different countries including speakers from Iceland, Myanmar, Australia, France, Canada, the US, Rwanda and Egypt.


The International Workshop on HIV Pediatrics will feature an exceptional program with invited lecturers, roundtable discussions, and interactive participation from delegates. The draft program is published below.

Download the program here

 Updated July 15


Friday 19 July 2019

 Session 1: Global Update on Pediatric HIV
 08:00Opening Words
Dr. Lynne Mofenson 
Dr. Noris Pavia-Ruz 
Dr. Guillermo Vazquez Rosales
 08:15Social Opening
Dr. Noris Pavia-Ruz 
Dr. Guillermo Vazquez Rosales
 08:302019 Update on the HIV Epidemic in Infants, Children, Adolescents and Women 
Mary Mahy, ScD, MHSc
UNAIDS, Switzerland
 08:45What's New from WHO on Pediatric Antiretroviral Therapy
Martina Penazzato
WHO, Switzerland
 09:00Population HIV Impact Assessments: What We Can Learn About Pediatric HIV
Suzue Saito, PhD
ICAP at Columbia University, USA
 Session 2: Pediatric Care and Treatment
 09:15Long-Acting and Innovative Formulations and Drug Delivery Devices: Possibilities for Children and Adolescents 
Charles Flexner, MD
Johns Hopkins Hospital, USA
 10:15Finding Kids, Treating Kids: Innovations in Case-Finding, Treatment and Care
Saeed Ahmed, MD, BA
Baylor College of Medicine, Malawi  
  10:45Oral Abstract Presentations
  12:30Lunch and Poster Viewing
 14:30Oral Abstract Presentations
  16:15Clinical Case Presentations 
Moderators: Gareth Tudor Williams and Noris Pavia-Ruz 
  Theodore Ruel 
University of California San Francisco, USA
  Jorge Pinto, MD, DSc
Federal University of Minas Gerais, Brazil
  Denis Tindyebwa , MBChB, MMed
African Network for the Care of Children Affected by HIV/AIDS (ANECCA), Uganda
  17:00Short Oral Poster Presentations 
  17:30 Poster Walk and Welcome Reception
 19:00Workshop Dinner

Saturday 20 July 2019

 7:30Morning Coffee
 08:00    SPECIAL SESSION: Tsepamo Update  
             Rebecca Zash
 Session 4: Prevention of New Pediatric HIV Infections and Improving Maternal Health
 9:00Update on Preconception ARVs and Birth Defects  
Claire Thorne, PhD
University College London, UK
 09:30Oral Abstract Presentations
 11:00Addressing Sexual and Reproductive Health Needs for Adolescent and Young Women in Low- and Middle-Income Countries
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP (SA), PhD
Desmond Tutu HIV Center, South Africa
 11:30Short Oral Poster Presentations
 12:00 Poster Viewing (Even Numbers)
 13:00 Lunch
 Session 4: Adolescents and Young Adults
 14:00DEBATE: Transition to Adult Care is Bad for the Health of HIV-Positive Youth  
Rachel Vreeman, MD, MS 
Icahn School of Medicine at Mount Sinai, USA
Hilda Mujuru, MBChB, MMed Paeds, MSc Clin Epi 
University of Zimbabwe, Zimbabwe
 14:30Oral Abstract Presentations
 16:15State of ART: Prevention of HIV in Adolescent and Young MSM
Nittaya Phanuphak, MD, PhD
Thai Red Cross AIDS Research Center 
 16:35State of ART: Prevention of HIV in Adolescent and Young Women
Quarraisha Abdool Karim, PhD
CAPRISA, South Africa
 16:55Youth Panel: What Should be Done for Prevention of HIV in Youth?
Youth Representatives
 17:25Young Investigator Award 





Day 1 - Saturday, 2 March 2019

 8:30 AMOpening of the workshop 
 Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy
Chairs: Catherine Hankins and Karoline Aebi-Popp
 08:45 AM

Clinical case: Researcher perspective
Tendani Gaolathe, MD - Botswana Harvard AIDS Institute Partnership, Botswana


09:15 AM

Clinical case: Community perspective
Lucy Wanjiku Njenga - Positive Young Women Voices, Kenya

 09:45 AM

Clinical case: Policy implications
Meg Doherty, MD, PhD - WHO, UK

 10:15 AM Discussion 
 10:30 AMGroup Picture 
 10:45 AMCoffee Break 
  Abstract-driven presentations 
 11:15 AM

INSTI exposure and neural tube defects –
data from antiretroviral pregnancy registry
Jessica Albano, PhD, MPH - Syneos Health, USA

 11:30 AM

Congenital anomalies in infants of Canadian women exposed to antiretrovirals including dolutegravir
Deborah Money, MD - UBC, Canada

 11:45 AM

Evaluation of neural tube defects after exposure to Raltegravir
during pregnancy

Hala Shamsuddin, MD - Merck, USA

 12:00 PMPanel discussion:  debaters, community, presenters 
  12:30 PMLunch
 Session 2: New drug delivery systems, are they right for women?
Chair: Sharon Walmsley
 01:30 PM

Invited lecture, focus on cabotegravir
Annemiek de Ruiter, MBBS FRCP, MD, ViiV Healthcare, UK

 02:00 PM

Emerging drug delivery systems for treatment and prevention of HIV

Kimberly Scarsi, PharmD, MS, University of Nebraska, USA

  Abstract-driven presentations
 02:30 PM

Clinical development strategy to inform dosing of antiretroviral drugs
in women: dolutegravir as a case study

Kimberly Adkison, PhD - Viiv Healthcare, USA

 2:45 PM

HIV risk and characteristics of women seeking PrEP
in a US demonstration project
Jill Blumenthal, MD - University of California, San Diago, USA

 03:00 PMDiscussion 
 03:15 PMCoffee Break 
 Session 3: Unique challenges of growing up with HIV
Chairs: Angelina Namiba and Teresia Otieno
 03:45 PM
Invited lecture: Unique challenges of growing up with HIV

Vanessa, CHIVA, UK
  Abstract-driven presentations 
 04:15 PMOptimizing HIV service delivery for young women who sell sex:
a discrete choice experiment
Sue Napierala, PhD, MPH - RTI International, USA
 04:30 PMHigh PrEP uptake among HIV-exposed women with pregnancy plans
in South Africa
Lynn Matthews, MD - University of Alabama at Birmingham, USA
 04:45 PMInnovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya
Elizabeth Okoth (presented by N. Rakhmanina), MPH -
Elizabeth Glaser Pediatric AIDS Foundation, Kenya
 05:00 PMDiscussion 
 5:15 PMWelcome drinks and poster viewing session 1 
  Guided poster tour 1: ARV and pregnancy issues  
  Altered levels of bioactive lipids in HIV and cART-exposed pregnancy
Kayode Balogun 
  Double-Dose Levonorgestrel Implant Does Not Fully Overcome
Drug-Drug Interaction with Efavirenz

Kimbery Scarsi 
  Lopinavir (an HIV protease inhibitor) impairs uterine remodeling
during pregnancy

Smriti Kala 
  Adverse pregnancy outcomes in HIV-positive pregnant women
on ART in Kenya

Lisa Abuogi 
  Adoption of an HIV-neutral approach to pregnancy care
in San Francisco, California

Dominika Seidman 
  Early antenatal care visit as it relates to prevention of
mother to child transmission of HIV in sub-Saharan Africa

Adewale Adefila 
 07:00 PMNetworking dinner 

Day 2 - Sunday, 3 March 2019

 Session 4: Healthy aging with HIV for women
Chair: Margaret Johnson
 08:30 AM
Bone Health among women aging with HIV
Michael Yin, MD, New York State Psychiatric Institute & Columbia University, USA
 09:00 AM
Cardiac Muscle Health Among Women Aging with HIV
Markella Zanni, MD, MGH/Harvard Medical School, USA
 09:30 AM
Important Drug- Drug interactions in Women aging with HIV
Marta Boffito, MD, PhD, SSAT & Imperial College, Chelsea and Westminster Hospital, UK
 10:00 AMDiscussion 
 10:15 AMCoffee break and poster viewing session 2 
  Guided poster tour 2: ARV in women  
  Efficacy of two-drug regimen of dolutegravir plus lamivudine (DTG+3TC) versus dolutegravir plus tenofovir/emtricitabine (DTG+TDF/FTC) at 48 weeks in antiretroviral naïve women: GEMINI studies subgroup analysis
Romina Quercia 
  Tenofovir Alafenamide vs Tenofovir DF in women: pooled analysis of 7 clinical trials
Melanie Thompson 
  Week 48 Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Women in the BRIGHTE Study
Peter Ackerman 
  Efficacy and Safety of the Once-daily Darunavir/Cobicistat/
Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Single-tablet Regimen in Antiretroviral Treatment (ART)-experienced and ARTnaïve Women Living with HIV-1: EMERALD and AMBER Week 96 Results

Aimee Wilkin 
  Guided poster tour 3: Comprehensive care in women  
  Prevalence of Cervical Dysplasia in HIV-positive Women Versus
HIV-negative Women: The Case of Zambia

Aimee Rurangwa 
  Reflections on a specialist HIV menopause service
Roberta Brum 
  38% of child bearing women with HIV in the UK would like to breastfeed-Results from PACIFY study group
Farai Nyatsanza 
  Risk of hospitalisation according to gender and ethnicity among
people living with HIV in the modern ART era

Sophia Rein 
  Depression symptom trajectories among mothers
living with HIV in rural Uganda

Itziar Familiar 
  Development and piloting of a scale to measure trauma- and
violence-aware principles of HIV care and practice for women
living with HIV in Metro Vancouver, Canada

Kathleen Deering 
 Session 5: Research in women and HIV - 1
Chairs:  Markella Zanni and Patricia Vasquez
Abstract-driven presentations
 11:30 AMNon-Vaccine Oncogenic HPV Persistence Among
HPV-Vaccinated Women Living with HIV

Elisabeth McClymont - University of British Columbia, Canada
 11:45 AMDolutegravir pharmacokinetics during pregnancy and postpartum
Angela Colbers, PhD - Radboud University Medical Center, The Netherlands
 12:00 AMIntimate Partner Violence, Depression, and Mortality among a Cohort
of Women living with HIV Marginalized by Socio-structural Inequities
in Vancouver, Canada

Kalysha Closson - University Of British Columbia, Canada
  12:15 AMVaginal microbiome and associations with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women
Melanie Nicol, PharmD, PhD - University of Minnesota, USA
 12:30 PMLunch 
 Session 6: HIV cure research - considerations for women
Chair: Natella Rakhmanina
 01:30 PM
HIV Cure: Where have we been, where are we going?
Daniel Kuritzkes, MD, Harvard Medical School, USA
 02:00 PM

Invited lecture:  Focus on women
Jintanat Ananworanich, MD, PhD,

US Military HIV Research Program, USA

  Abstract-driven presentation 
 02:30 PMWomen’s involvement in clinical research: Women included
in Dolutegravir clinical trials versus collaborative studies

Romina Quercia, MD, PhD, MPH - ViiV Healthcare, UK
 02:45 PMDiscussion 
 03:00 PMClosing of the workshop 



MET18 will feature regional and international prominent and distinguished speakers that will discuss the most current and trending issues in the field. Delegates can look forward to an exciting and highly interactive program that will facilitate a neutral, scientific, knowledge exchange. 

Preliminary program

Day 1

13.00hRegistration and welcome lunch
  14.00hSession 1: Hepatitis C - Situation in the Region
16.00hTea/Coffee Break
  16.30hSession 2 - Viral Hepatitis (HCV)
18.00hWelcome Reception & Poster Viewing

Day 2

  8.30hSession 3: Viral Hepatitis (HBV)
10.30hTea/Coffee Break & Poster viewing
  11.00hSession 4: End Stage Liver Disease / NASH / NAFLD
  14.00hSession 5: Hepatitis C Elimination
16.00hClosure of the workshop





Monday October 2 - Day 1

8:30 Opening of the workshop
Session 1: Biological aging

Phenotype of aging
George Kuchel, MD - UCONN Health Center of Aging, Farmington, CT, USA


Clinical Trials Targeting Aging to Extend Healthy Lifespan
Jamie Justice, PhD - Wake Forest School of Medicine, Winston-Salem, NC, USA

9:45 The biology of superagers
Nir Barzilai, MD - Albert Einstein College of Medicine, New York, NY, USA
10:30Coffee break
Session 2: Biological aging : abstract-driven presentations
11:00Inability of ART to Restore Age-Appropriate Epigenetic Patterns in HIV-Infected Adults
Dr Beth Jamieson-Karavodin, David Geffen - School of Medicine at UCLA, USA
11:15Mitochondrial DNA variation associated with gait speed decline among older HIV-infected non-Hispanic white males
Jing Sun - Johns Hopkins Bloomberg School Of Public Health, USA
11:30Limited evidence of biological aging in early-treated HIV-infected children
Stephanie Shiau - Columbia University, USA
11:45 Metformin suppresses human cytomegalovirus infection: an underlying mechanism for metformin’s “geroprotective” effect?
Sean Leng - Johns Hopkins University School of Medicine, USA
12:00 Discussion
12:15 Group picture
12:30 Lunch
Session 3: Aging and CNS safety of HIV interventions
13:30HIV eradication strategies and the CNS
Serena Spudich, MD - Yale University, New Haven, NY, USA
14:00Antiretroviral neurotoxicity in aging adults
Scott Letendre, MD - University of California, San Diego, CA, USA
14:45Coffee break and poster viewing session 1
Session 4: Aging and CNS safety of HIV interventions: abstract-driven presentations
15:45OMICS in the context of Aging and Alzheimer's disease
Madhav Thambisetty, MD - NIA / NIH, Baltimore, MD, USA
 Abstract driven presentations:
16:15Common SNPs in the HFE (Hemochromatosis) Gene are Associated with Neurocognitive Impairment and Aging-Related Neurodegenerative Processes in HIV+ Adults
Asha Kallianpur  - Cleveland Clinic Foundation, USA
16:30Lower cerebral blood flow and elevated chronic monocyte activation correlate with cognitive impairment in well-controlled older HIV+ individuals
Tricia Burdo - Temple University Lewis Katz School Of Medicine, USA
16:45Cognition, Mood and Quality of Life in 706 HIV+ Men in Canada
Marie-Josée Brouillette - McGill University Health Centre, Canada
17:00Cognitive Impairment in Symptomatic HIV Over age 60
Shireen Javandel - UC San Francisco, Memory & Aging Center, USA
17:30Welcome drinks and poster viewing session 2
19:00Workshop dinner (on pre-registration only)

Tuesday 3 October - Day 2

Session 5: The effect of exercise and diet on aging

Exercise and aging
Wendy Kohrt, PhD - University of Colorado, Denver, CO, USA

8:30 Stress and aging
Gretchen Neigh, PhD - Virginia Commonwealth University, Richmond, VA, USA
9:00Interrelationships of nutrition and aging
Connie Bales, PhD - Duke University, Durham, NC, USA


10:00Coffee break and poster viewing session 3
Session 6: The effect of exercise and diet on aging: abstract-driven presentations
10:45Adherence to recommendations from comprehensive geriatric assessment in an HIV+ population
Christiana Bitas - Weill Cornell Medical College, USA
11:00Lean mass declines consistently over 10 Years in HIV-Infected adults on antiretroviral therapy, with patterns differing by sex
Jordan Lake - UTHealth, USA
11:15Steps count is associated with adverse health outcomes in HIV patients better than traditional HIV variables
Giovanni Guaraldi - University of Modena, Italy
11:30The relationships between CD4+ and CD8+ T-cell responses to human cytomegalovirus, circulating inflammatory markers, and frailty in HIV- and HIV+ men in the Multicenter AIDS Cohort Study
Joseph Margolick - Johns Hopkins Bloomberg School of Public Health, USA
11:45 Discussion

Session 7: Delivering research progress to patients
Chairs: Jules Ievin, Julian Falutz, Kristine Erlandson

13:00Current reality: The San Francisco experience
Meredith Greene, MD - UCSF School of Medicine, San Francisco, CA, USA

Current reality: The New York experience
Eugenia Siegler, MD - Weill Cornell Medical College, New York, NY, USA

Round Table Discussion:

14:00The community perspective
Jules Levin, MS - NATAP, New York, USA.

The researcher perspective
Phyllis Tien, MD - University of California, San Francisco, CA, USA

14:40The NIH perspective
Maureen Goodenow, PhD - NIH / OAR, Bethesda, MD, USA
15:00Panel discussion
15:30Closing remarks



The final program, including the abstract presentations, can be downloaded here: 13th Coinfection - Online program